Latest glioblastoma multiforme Stories
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma.
In this phase two study, 50 percent of glioblastoma patients lived for two years, an encouraging result for one of the most deadly cancers that often kills patients within one year of diagnosis
SAN ANTONIO, June 30, 2014 /PRNewswire/ -- GenSpera, Inc.
Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'.
HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc.
G-202 Data in HCC Patients (Phase I and Phase II) Highly Suggestive of Positive Clinical Activity SAN ANTONIO, June 24, 2014 /PRNewswire/ -- GenSpera, Inc.
SAN ANTONIO, June 23, 2014 /PRNewswire/ -- GenSpera, Inc.
Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company
SAN ANTONIO, June 19, 2014 /PRNewswire/ -- GenSpera, Inc.
- An imitative word; an onomatopoetic word.